Related Experiment Video
Updated: Jun 13, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Targeting Notch signaling in pancreatic cancer
Elodie Ristorcelli1, Dominique Lombardo
1INSERM UMR 911-CR02, Faculty of Medicine, 27 BL Jean Moulin, Marseille 13005, France.
Importance Of The Field:
With some 220,000 new cases/year in the world, pancreatic adenocarcinoma is the fourth highest cause of death by cancers. Among newly diagnosed patients about 210,000 will die within 9 months following diagnosis. Therefore, effective adjuncts to current treatment strategies are necessary. Because embryological signaling pathways are upregulated in pancreatic adenocarcinoma, they represent potential targets for future therapies.
Areas Covered In This Review:
Our aim is to present the Notch pathway, and to describe its involvement in pancreatic pathophysiology/carcinogenesis. This pathway appeared as a prime target for pancreatic cancer therapy. In the light of the crosstalk of Notch with other survival/embryologic pathways, drugs affecting more than one pathway may have to be combined.
What The Reader Will Gain:
Drugs against gamma-secretases could thus serve in cancer treatment and can be combined with drugs targeting survival pathways interplaying with Notch such as Hedgehog.
Take Home Message:
Downregulation of Notch contributes to the inhibition and apoptosis of pancreatic cancer cells whereas Hedgehog inhibition will allow for enhanced delivery of drugs to the tumor. Both pathway inhibitors appear to have synergistic effects for future therapeutics for pancreatic adenocarcinoma, once safety issues of compounds are overcome.
Insights
Pancreatic cancer therapy can be improved by targeting the Notch and Hedgehog pathways. Inhibiting Notch induces cancer cell apoptosis, while Hedgehog inhibition enhances drug delivery, suggesting synergistic effects for future pancreatic adenocarcinoma treatments.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling Pathways
Background:
- Pancreatic adenocarcinoma is a leading cause of cancer death globally, with poor prognosis.
- Current treatments require adjuncts due to rapid disease progression and high mortality.
- Embryonic signaling pathways, including Notch, are implicated in pancreatic cancer development.
Purpose of the Study:
- To review the Notch pathway's role in pancreatic pathophysiology and carcinogenesis.
- To highlight Notch as a therapeutic target for pancreatic cancer.
- To explore combination therapies involving Notch and other signaling pathways.
Main Methods:
- Review of existing literature on the Notch pathway in pancreatic cancer.
- Analysis of the crosstalk between Notch and other survival pathways.
- Discussion of potential therapeutic strategies targeting these pathways.
Main Results:
- Gamma-secretase inhibitors show potential for pancreatic cancer treatment.
- Combination therapy with drugs targeting survival pathways (e.g., Hedgehog) may be beneficial.
- Notch pathway modulation affects pancreatic cancer cell apoptosis and drug delivery.
Conclusions:
- Notch pathway downregulation inhibits pancreatic cancer cell growth and promotes apoptosis.
- Hedgehog pathway inhibition can improve drug delivery to pancreatic tumors.
- Combined inhibition of Notch and Hedgehog pathways demonstrates synergistic potential for pancreatic adenocarcinoma therapeutics, pending safety evaluations.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

